INSIGHTS ON DRUG DEVELOPMENT
-
Aggregate Analysis Of Tirzepatide
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
mRNA Vaccines And Therapeutics: Current Trends And Perspectives
Delve into the advancements and transformative impact of mRNA vaccine technology on modern medicine and explore how this technology is revolutionizing healthcare for the future and beyond.
-
Overcome Early Development Challenges Before They Impact Your Program
Poor manufacturability and immunogenicity can delay development. Learn how early developability assessments support IND readiness.
-
Getting The Most Out Of Cell-Based Assays With The Optimal Read Function
Gain insight into a whole-well fluorescence analysis that improves sensitivity and reproducibility in cell-based assays by accounting for uneven cell distribution.
-
Enabling Process Monitoring, Product Characterization, And Quality Control9/16/2026
Optical microscopy reveals biological structures, behaviors, and interactions throughout development. Learn how advanced imaging and analysis support cellular research and more.
-
Solutions For CQA Analysis Of IVT mRNA-Based Biotherapeutics2/20/2025
Discover new innovative solutions for mRNA analysis, enhancing accuracy and efficiency in IVT mRNA workflows, including advanced technologies and methodologies to optimize your research and development processes.
-
Denaturing SEC-MS Analysis Of High Molecular Weight Impurities3/18/2026
Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.
-
Assessing The Success Of CRISPR Gene Therapies Using ddPCR Technology3/4/2026
Achieve high-fidelity results in gene therapy research. Discover how absolute quantification overcomes traditional limitations to provide the precision needed for validating CRISPR edits.
-
Integration From Formulation Development To Manufacturing, Packaging2/27/2025
Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.
DRUG DEVELOPMENT SOLUTIONS
-
At Acceleration Hub, we work with emerging biotech companies and large pharma partners, combining route selection, process development, analytical capabilities, and manufacturing into one coordinated approach - including expertise in highly potent APIs and controlled substances.
With experienced teams, established processes, and dedicated infrastructure, we enable efficient project progression under tight timelines and evolving requirements.
-
Observe the viability of your cells with the field-upgradeable cellular imaging option for the SpectraMax i3/i3x Multi-mode Detection Platform.
-
Rules-Based Fragment Prediction for Mass Spectrometry
ACD/MS Fragmenter helps you predict mass spectral fragmentation in seconds. Have more confidence in your compound IDs, learn about fragmentation mechanisms, and publish your results easily.
It’s as simple as this:
- Draw your compound
- Select the ionization polarity and fragmentation options
- View its fragmentation tree
-
Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.
-
From formulation design to commercial supply, pediatric drug development requires expertise that supports accurate dosing, usability and scale.